空间基因组学和转录组学市场 - 2018-2028 年全球行业规模、份额、趋势、机会和预测，按技术、产品类型、按应用、最终用户、地区和竞争细分

预计空间基因组学和转录组学市场在预测期内将出现令人印象深刻的增长。这可以归因于对早期诊断和治疗的需求不断增长以及慢性病治疗创新产品的开发。此外，基于细胞的研究资金的增加以及癌症研究新型细胞测定的需求不断增长是预测期内推动全球空间基因组学和转录组学市场增长的主要因素。 2020年，Cancer Transcriptome Atlas推出了基于NanoString Technologies的新产品，并推出了名为GeoMx Digital Spatial Profiler（DSP）平台的新平台，用于Illumina下一代测序（NGS）技术上的读数。

对个性化医疗的需求不断增加

个性化医疗是全球空间基因组学和转录组学市场增长的关键驱动力之一。个性化医疗涉及利用基因组信息为个体患者量身定制治疗方案，目的是改善治疗结果并减少不良反应。空间基因组学和转录组学可以更全面地了解基因的组织和功能，从而更容易为患有復杂疾病的患者开发个性化治疗。

慢性病患病率不断上升

癌症、心血管疾病和糖尿病等慢性病的患病率不断上升，是预测期内推动全球空间基因组学和转录组学市场增长的主要因素。空间基因组学和转录组学有助于慢性病的早期检测、诊断和治疗，从而改善患者的治疗效果。空间基因组学和转录组学使研究人员能够研究特定组织（例如癌细胞）中基因的组织和功能。这使得能够识别与慢性疾病的发生和进展相关的基因和基因表达模式。通过了解这些疾病背后的分子机制，研究人员可以开发出更有针对性和更有效的新疗法。空间基因组学和转录组学可用于监测患者对治疗的反应，从而根据需要对治疗进行个性化调整。这有助于改善治疗结果并降低不良反应的风险。这导致研发投资增加，包括在药物发现和开发中采用空间基因组学和转录组学。

研发投资不断增加

研究与开发（R&D）是推动全球空间基因组学和转录组学市场增长的关键因素。技术进步、新产品开发和不断增加的研发投资正在推动市场的增长。随着空间基因组学和转录组学新应用的发现，对新的和改进的产品和技术的需求不断增长。这正在推动空间基因组学和转录组学新仪器、软件和耗材的开发。随着公司寻求从竞争对手中脱颖而出并获得市场份额，新产品和新技术的推出正在推动市场增长。

此外，研发投资对于空间基因组学和转录组学的持续发展至关重要。随着该技术得到更广泛的采用，对新的创新应用和新技术的开发的需求不断增长，以进一步提高该技术的准确性和灵敏度。研发投资对于解决市场面临的挑战是必要的，例如仪器和耗材的高成本以及数据分析的复杂性。政府资助和私人研发投资正在推动全球空间基因组学和转录组学市场的增长。政府和私人投资者正在认识到该技术的潜力，并为研究提供资金，这正在加速新应用和技术的开发。

测序和微阵列技术的进步

测序和微阵列技术是推动全球空间基因组学和转录组学市场增长的关键因素。这两种技术在使研究人员能够研究特定组织中基因的组织和功能方面发挥着至关重要的作用。新一代测序 (NGS) 等测序技术可以对单个细胞或组织的 DNA 或 RNA 进行测序，从而提供转录组或基因组的高分辨率视图。这允许识别与特定组织、细胞类型或疾病相关的基因和基因表达模式。

测序技术在空间基因组学和转录组学中得到广泛采用，以识别复杂组织（例如大脑、肿瘤微环境和免疫细胞）中的细胞类型和细胞相互作用。另一方面，微阵列技术可以同时检测许多基因的基因表达模式。微阵列可用于研究单个细胞或组织中的基因表达，或在大规模实验中用于识别与特定疾病相关的生物标誌物或基因特征。

空间分辨微阵列技术，例如 Nanostring nCounter 系统，可以同时检测单个细胞或小组织区域的基因表达。空间基因组学和转录组学中测序和微阵列技术的采用正在推动新应用和产品的开发，例如空间分辨转录组学和单细胞测序。随着更多的研究人员和公司可以访问和利用这些技术，这些技术的可用性正在推动市场的增长。

增加生物信息学的采用

生物信息学是推动全球空间基因组学和转录组学市场增长的关键因素。空间基因组学和转录组学产生大量数据，这些数据的分析和解释需要先进的计算工具和算法。生物信息学为空间基因组学和转录组学数据的分析和解释提供了必要的工具和技术。生物信息学工具使研究人员能够识别特定组织中基因表达和基因组组织的模式，并了解基因和蛋白质之间的功能关係。这些工具还能够将空间基因组学和转录组学数据与其他类型的基因组学和蛋白质组学数据整合，从而能够更全面地了解基因功能和调控。

生物信息学工具的可用性正在推动空间基因组学和转录组学新应用和产品的开发。公司正在开发软件平台和分析工具，使研究人员能够分析和可视化空间基因组学和转录组学数据，并将这些数据与其他类型的基因组和蛋白质组数据集成。生物信息学工具的可用性正在推动市场的增长，因为更多的研究人员和公司可以访问和利用该技术。开源生物信息学工具和数据库（例如艾伦脑图谱）的发展正在推动市场的增长，因为这些工具使研究人员能够访问和分析来自各种来源的空间基因组学和转录组学数据。

近期发展

• 10x Genomics Visium 空间基因表达解决方案：该解决方案于 2019 年推出，能够对基因表达和组织形态进行原位高通量分析，使研究人员能够了解细胞和组织的空间组织。
• NanoString GeoMx 数字空间分析仪：该平台于 2018 年推出，可提供组织中 RNA 和蛋白质表达的高分辨率空间分析，从而能够表征复杂的细胞环境和识别疾病生物标誌物。
• Cartana 空间转录组学试剂盒：该试剂盒于 2020 年推出，能够原位捕获和分析 RNA 表达数据，使研究人员能够研究复杂组织结构内的基因表达模式。
• Akoya Biosciences Phenoptics 2.0：该成像平台于 2021 年推出，能够对组织样本进行多重分析，将空间分析与表型分析相结合，以提供对细胞功能的更全面的了解。
• Fluidigm Advanta Spatial Transcriptomics：该技术于 2019 年推出，可以原位捕获和分析 RNA 表达数据，提供有关组织中基因表达模式的高分辨率空间信息。

可用的定制：

根据给定的市场数据，TechSci Research 可根据公司的具体需求提供定制服务。该报告可以使用以下自定义选项：

公司信息

• 其他市场参与者（最多五个）的详细分析和概况分析。

目录

第 1 章：产品概述

• 市场定义
• 市场范围
  • 涵盖的市场
  • 考虑学习的年份
  • 主要市场细分

第 2 章：研究方法

• 研究目的
• 基线方法
• 主要行业合作伙伴
• 主要协会和二手资料来源
• 预测方法
• 数据三角测量和验证
• 假设和限制

第 3 章：执行摘要

• 市场概况
• 主要市场细分概述
• 主要市场参与者概述
• 重点地区/国家概况
• 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球空间基因组学和转录组学市场展望

• 市场规模及预测
  • 按价值
• 市场份额及预测
  • 按技术分类（空间转录组学与空间基因组学分析）
  • 按产品类型（仪器、消耗品、软件）
  • 按应用（转化研究与药物发现和开发）
  • 按最终用户（製药和生物技术公司、合同研究组织、学术和研究机构）
  • 按地区（北美、欧洲、亚太地区、南美、中东和非洲）
  • 按公司划分 (2022)
• 市场地图
  • 按技术
  • 按产品类型
  • 按应用
  • 按最终用户
  • 按地区

第 6 章：北美空间基因组学和转录组学市场展望

• 市场规模及预测
  • 按价值
• 市场份额及预测
  • 按技术分类（空间转录组学与空间基因组学分析）
  • 按产品类型（仪器、消耗品、软件）
  • 按应用（转化研究与药物发现和开发）
  • 按最终用户（製药和生物技术公司、合同研究组织、学术和研究机构）
  • 按国家/地区
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第 7 章：欧洲空间基因组学和转录组学市场展望

• 市场规模及预测
  • 按价值
• 市场份额及预测
  • 按技术分类（空间转录组学与空间基因组学分析）
  • 按产品类型（仪器、消耗品、软件）
  • 按应用（转化研究与药物发现和开发）
  • 按最终用户（製药和生物技术公司、合同研究组织、学术和研究机构）
  • 按国家/地区
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 意大利
  • 西班牙

第 8 章：亚太空间基因组学和转录组学市场展望

• 市场规模及预测
  • 按价值
• 市场份额及预测
  • 按技术分类（空间转录组学与空间基因组学分析）
  • 按产品类型（仪器、消耗品、软件）
  • 按应用（转化研究与药物发现和开发）
  • 按最终用户（製药和生物技术公司、合同研究组织、学术和研究机构）
  • 按国家/地区
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳大利亚

第 9 章：南美空间基因组学和转录组学市场展望

• 市场规模及预测
  • 按价值
• 市场份额及预测
  • 按技术分类（空间转录组学与空间基因组学分析）
  • 按产品类型（仪器、耗材、软件）
  • 按应用（转化研究与药物发现和开发）
  • 按最终用户（製药和生物技术公司、合同研究组织、学术和研究机构）
  • 按国家/地区
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲空间基因组学和转录组学市场展望

• 市场规模及预测
  • 按价值
• 市场份额及预测
  • 按技术分类（空间转录组学与空间基因组学分析）
  • 按产品类型（仪器、消耗品、软件）
  • 按应用（转化研究与药物发现和开发）
  • 按最终用户（製药和生物技术公司、合同研究组织、学术和研究机构）
  • 按国家/地区
• MEA：国家分析
  • 南非空间基因组学和转录组学
  • 沙特阿拉伯空间基因组学和转录组学
  • 阿联酋空间基因组学和转录组学

第 11 章：市场动态

• 司机
  • 对实验室自动化活动的需求不断增长
  • 生物样本库越来越多地采用实验室信息学
  • 越来越多地引入技术先进的软件服务
• 挑战
  • 缺乏实验室信息学集成标准
  • 严格的规定

第 12 章：市场趋势与发展

• 近期发展
• 併购
• 产品发布

第 13 章：全球空间基因组学和转录组学市场：SWOT 分析

第 14 章：波特的五力分析

• 行业竞争
• 新进入者的潜力
• 供应商的力量
• 客户的力量
• 替代产品的威胁

第15章：竞争格局

• 商业概览
• 产品供应
• 最近的发展
• 财务（据报导）
• 主要人员
• SWOT分析
  • 10X Genomics Inc.
  • Akoya Bioscience Ltd.
  • Biospyder Technologies Inc.
  • BioTechne Corporation.
  • Dovetail Genomics LLC.
  • Fluidigm Corporation.
  • Genomic Vision SA.
  • Illumina Inc.
  • Lunaphore Technologies SA.
  • Nanostring Technolgies Inc.

第 16 章：战略建议

Spatial Genomics and Transcriptomics Market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the growing demand for early diagnosis and remedial treatment and the development of innovative products for the treatment of chronic diseases. Also, increasing funding for cell-based research and growing demand for novel cell assays for cancer research are the major factors for driving the growth of the Global Spatial Genomics and Transcriptomics Market during the forecast period. In 2020, Cancer Transcriptome Atlas launched a new product based on NanoString Technologies and launched a new platform called as GeoMx Digital Spatial Profiler (DSP) platform, which is used for readout on Illumina's next-generation sequencing (NGS) technology.

Increasing Demand for Personalized Medicine

Personalized medicine is one of the key drivers of the growth of Global Spatial Genomics and Transcriptomics Market. Personalized medicine involves the use of genomic information to tailor treatments to individual patients, with the aim of improving treatment outcomes and reducing adverse effects. Spatial genomics and transcriptomics provide a more comprehensive understanding of the organization and function of genes, making it easier to develop personalized treatments for patients with complex diseases.

Spatial genomics and transcriptomics can help to identify specific genes and their expression patterns that are associated with disease, allowing for more targeted and effective therapies. This can be particularly beneficial for patients with cancer, as spatial genomics and transcriptomics can help to identify genetic changes that lead to the development and progression of cancer. Spatial genomics and transcriptomics can be used to monitor the response of patients to treatment, allowing for personalized adjustments to be made to their therapy as needed. This can help to improve treatment outcomes and reduce the risk of adverse effects. The growing demand for personalized medicine is driving the adoption of spatial genomics and transcriptomics in the biotechnology and pharmaceutical industry, as well as in academic and research institutions. This is leading to the development of new applications for the technology, which is expected to further drive the growth of the global spatial genomics and transcriptomics market in the coming years.

Growing Prevalence of Chronic Diseases

The increasing prevalence of Chronic diseases, such as cancer, cardiovascular disease, and diabetes, is a major factor that will drive the growth of the Global Spatial Genomics and Transcriptomics Market during the forecast period. Spatial genomics and transcriptomics can help in the early detection, diagnosis, and treatment of chronic diseases, leading to better patient outcomes. Spatial genomics and transcriptomics enable researchers to study the organization and function of genes in specific tissues, such as cancer cells. This allows for the identification of genes and gene expression patterns that are associated with the development and progression of chronic diseases. By understanding the molecular mechanisms underlying these diseases, researchers can develop new treatments and therapies that are more targeted and effective. Spatial genomics and transcriptomics can be used to monitor the response of patients to treatment, allowing for personalized adjustments to be made to their therapy as needed. This can help to improve treatment outcomes and reduce the risk of adverse effects. This is leading to increased investment in research and development, including the adoption of spatial genomics and transcriptomics in drug discovery and development.

Rising Investment in Research & Development

Research & development (R&D) is a crucial factor in driving the growth of the Global Spatial Genomics and Transcriptomics Market. Advancements in technology, new product development, and increasing R&D investment are driving the growth of the market. As new applications of spatial genomics and transcriptomics are discovered, there is a growing need for new and improved products and technologies. This is driving the development of new instruments, software, and consumables for spatial genomics and transcriptomics. The introduction of new products and technologies is driving market growth as companies seek to differentiate themselves from competitors and gain market share.

In addition, R&D investment is critical to the continued development of spatial genomics and transcriptomics. As the technology becomes more widely adopted, there is a growing need for new and innovative applications and the development of new technologies that can further improve the accuracy and sensitivity of the technology. R&D investment is necessary to address the challenges facing the market, such as the high cost of instruments and consumables and the complexity of data analysis. Government funding and private investment in R&D are driving the growth of the global spatial genomics and transcriptomics market. Governments and private investors are recognizing the potential of the technology and are providing funding for research, which is accelerating the development of new applications and technologies.

Advancements in Sequencing and Microarray Technologies

Sequencing and microarray technologies are key factors driving the growth of the Global Spatial Genomics and Transcriptomics Market. Both technologies play a crucial role in enabling researchers to study the organization and function of genes in specific tissues. Sequencing technologies, such as next-generation sequencing (NGS), enable the sequencing of DNA or RNA from individual cells or tissues, providing a high-resolution view of the transcriptome or genome. This allows for the identification of genes and gene expression patterns that are associated with specific tissues, cell types, or diseases.

Sequencing technologies are being widely adopted in spatial genomics and transcriptomics to enable the identification of cell types and cell interactions in complex tissues, such as the brain, tumor microenvironments, and immune cells. Microarray technologies, on the other hand, enable the detection of gene expression patterns in many genes simultaneously. Microarrays can be used to study gene expression in individual cells or tissues or in large-scale experiments to identify biomarkers or gene signatures associated with specific diseases.

Spatially resolved microarray technologies, such as the Nanostring nCounter system, allow simultaneous detection of gene expression in individual cells or small tissue regions. The adoption of sequencing and microarray technologies in Spatial Genomics and Transcriptomics is driving the development of new applications and products, such as spatially resolved transcriptomics and single-cell sequencing. The availability of these technologies is driving the growth of the market as more researchers and companies can access and utilize the technology.

Increasing Adoption of Bioinformatics

Bioinformatics is a crucial factor driving the growth of the Global Spatial Genomics and Transcriptomics Market. Spatial genomics and transcriptomics generate large volumes of data, and the analysis and interpretation of this data require advanced computational tools and algorithms. Bioinformatics provides the necessary tools and techniques for the analysis and interpretation of spatial genomics and transcriptomics data. Bioinformatics tools enable researchers to identify patterns in gene expression and genomic organization in specific tissues and to understand the functional relationships between genes and proteins. These tools also enable the integration of spatial genomics and transcriptomics data with other types of genomic and proteomic data, enabling a more comprehensive understanding of gene function and regulation.

The availability of bioinformatics tools is driving the development of new applications and products in spatial genomics and transcriptomics. Companies are developing software platforms and analysis tools that enable researchers to analyze and visualize spatial genomics and transcriptomics data and integrate this data with other types of genomic and proteomic data. The availability of bioinformatics tools is driving the growth of the market, as more researchers and companies can access and utilize the technology. The development of open-source bioinformatics tools and databases, such as the Allen Brain Atlas, is driving the growth of the market, as these tools enable researchers to access and analyze spatial genomics and transcriptomics data from a variety of sources.

Recent Development

• 10x Genomics Visium Spatial Gene Expression Solution: Launched in 2019, this solution enables the high-throughput analysis of gene expression and tissue morphology in situ, allowing researchers to understand the spatial organization of cells and tissues.
• NanoString GeoMx Digital Spatial Profiler: Launched in 2018, this platform provides high-resolution spatial profiling of RNA and protein expression in tissues, enabling the characterization of complex cellular environments and the identification of disease biomarkers.
• Cartana Spatial Transcriptomics Kit: Launched in 2020, this kit enables the capture and analysis of RNA expression data in situ, allowing researchers to study gene expression patterns within complex tissue structures.
• Akoya Biosciences Phenoptics 2.0: Launched in 2021, this imaging platform enables the multiplexed analysis of tissue samples, combining spatial profiling with phenotypic analysis to provide a more comprehensive understanding of cellular function.
• Fluidigm Advanta Spatial Transcriptomics: Launched in 2019, this technology allows for the capture and analysis of RNA expression data in situ, providing high-resolution spatial information about gene expression patterns in tissues.

Market Segmentation

Global Spatial Genomics and Transcriptomics market can be segmented by technique, product type, application, end-user, and region. Based on the technique, the market can be divided into spatial transcriptomics and spatial genomics analysis. Based on product type, the market can be segmented into instruments, consumables, and software. Based on application, the market can be divided into Translational Research and Drug discovery & development. Based on end-user, the market can be differentiated into pharmaceutical & biotechnology companies, contract research organizations, and academic & research institutes.

Market Players

10X Genomics Inc., Akoya Bioscience Ltd., Biospyder Technologies Inc., BioTechne Corporation., Dovetail Genomics LLC., Fluidigm Corporation., Genomic Vision SA., Illumina Inc., Lunaphore Technologies SA., Nanostring Technolgies Inc. are some of the leading players operating in the Global Spatial Genomics and Transcriptomics Market.

Report Scope:

In this report, Global Spatial Genomics and Transcriptomics market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Spatial Genomics and Transcriptomics Market, By Technique:

• Spatial Transcriptomics
• Spatial Genomics Analysis

Spatial Genomics and Transcriptomics Market, By Product Type:

• Instruments
• Consumables
• Software

Spatial Genomics and Transcriptomics Market, By Application:

• Translational Research
• Drug discovery & development

Spatial Genomics and Transcriptomics Market, By End User:

• Pharmaceutical & Biotechnology companies
• Contract Research Organizations
• Academic & Research Institutes

Spatial Genomics and Transcriptomics Market, By Region:

• North America
  • United States
  • Canada
  • Mexico

• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain

• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia

• South America
  • Brazil
  • Argentina
  • Colombia

• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Spatial Genomics and Transcriptomics Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Spatial Genomics and Transcriptomics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Technique (Spatial Transcriptomics v/s Spatial Genomics Analysis)
  • 5.2.2. By Product Type (Instruments, Consumables, Software)
  • 5.2.3. By Application (Translational Research v/s Drug discovery & development)
  • 5.2.4. By End User (Pharmaceutical & Biotechnology companies, Contract Research Organizations, Academic & Research Institutes)
  • 5.2.5. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
  • 5.2.6. By Company (2022)
• 5.3. Market Map
  • 5.3.1 By Technique
  • 5.3.2 By Product Type
  • 5.3.3 By Application
  • 5.3.4 By End User
  • 5.3.5 By Region

6. North America Spatial Genomics and Transcriptomics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Technique (Spatial Transcriptomics v/s Spatial Genomics Analysis)
  • 6.2.2. By Product Type (Instruments, Consumables, Software)
  • 6.2.3. By Application (Translational Research v/s Drug discovery & development)
  • 6.2.4. By End User (Pharmaceutical & Biotechnology companies, Contract Research Organizations, Academic & Research Institutes)
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Spatial Genomics and Transcriptomics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Technique
      • 6.3.1.2.2. By Product Type
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Spatial Genomics and Transcriptomics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Technique
      • 6.3.2.2.2. By Product Type
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Spatial Genomics and Transcriptomics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Technique
      • 6.3.3.2.2. By Product Type
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End User

7. Europe Spatial Genomics and Transcriptomics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Technique (Spatial Transcriptomics v/s Spatial Genomics Analysis)
  • 7.2.2. By Product Type (Instruments, Consumables, Software)
  • 7.2.3. By Application (Translational Research v/s Drug discovery & development)
  • 7.2.4. By End User (Pharmaceutical & Biotechnology companies, Contract Research Organizations, Academic & Research Institutes)
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Spatial Genomics and Transcriptomics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Technique
      • 7.3.1.2.2. By Product Type
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User
  • 7.3.2. Germany Spatial Genomics and Transcriptomics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Technique
      • 7.3.2.2.2. By Product Type
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Spatial Genomics and Transcriptomics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Technique
      • 7.3.3.2.2. By Product Type
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Spatial Genomics and Transcriptomics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Technique
      • 7.3.4.2.2. By Product Type
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Spatial Genomics and Transcriptomics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Technique
      • 7.3.5.2.2. By Product Type
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End User

8. Asia-Pacific Spatial Genomics and Transcriptomics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Technique (Spatial Transcriptomics v/s Spatial Genomics Analysis)
  • 8.2.2. By Product Type (Instruments, Consumables, Software)
  • 8.2.3. By Application (Translational Research v/s Drug discovery & development)
  • 8.2.4. By End User (Pharmaceutical & Biotechnology companies, Contract Research Organizations, Academic & Research Institutes)
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Spatial Genomics and Transcriptomics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Technique
      • 8.3.1.2.2. By Product Type
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User
  • 8.3.2. India Spatial Genomics and Transcriptomics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Technique
      • 8.3.2.2.2. By Product Type
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Spatial Genomics and Transcriptomics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Technique
      • 8.3.3.2.2. By Product Type
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Spatial Genomics and Transcriptomics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Technique
      • 8.3.4.2.2. By Product Type
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Spatial Genomics and Transcriptomics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Technique
      • 8.3.5.2.2. By Product Type
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End User

9. South America Spatial Genomics and Transcriptomics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Technique (Spatial Transcriptomics v/s Spatial Genomics Analysis)
  • 9.2.2. By Product Type (Instruments, Consumables, Software)
  • 9.2.3. By Application (Translational Research v/s Drug discovery & development)
  • 9.2.4. By End User (Pharmaceutical & Biotechnology companies, Contract Research Organizations, Academic & Research Institutes)
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Spatial Genomics and Transcriptomics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Technique
      • 9.3.1.2.2. By Product Type
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina Spatial Genomics and Transcriptomics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Technique
      • 9.3.2.2.2. By Product Type
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia Spatial Genomics and Transcriptomics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Technique
      • 9.3.3.2.2. By Product Type
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User

10. Middle East and Africa Spatial Genomics and Transcriptomics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Technique (Spatial Transcriptomics v/s Spatial Genomics Analysis)
  • 10.2.2. By Product Type (Instruments, Consumables, Software)
  • 10.2.3. By Application (Translational Research v/s Drug discovery & development)
  • 10.2.4. By End User (Pharmaceutical & Biotechnology companies, Contract Research Organizations, Academic & Research Institutes)
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Spatial Genomics and Transcriptomics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Technique
      • 10.3.1.2.2. By Product Type
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia Spatial Genomics and Transcriptomics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Technique
      • 10.3.2.2.2. By Product Type
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE Spatial Genomics and Transcriptomics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Technique
      • 10.3.3.2.2. By Product Type
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
  • 11.1.1 Growing demand for lab automation activities
  • 11.1.2 Growing adoption of lab informatics by biobanks
  • 11.1.3 Growing introduction of technologically advanced software services
• 11.2. Challenges
  • 11.2.1 Lack of integration standards for laboratory informatics
  • 11.2.2 Stringent Regulations

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Spatial Genomics and Transcriptomics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Business Overview
• 15.2. Product Offerings
• 15.3. Recent Developments
• 15.4. Financials (As Reported)
• 15.5. Key Personnel
• 15.6. SWOT Analysis
  • 15.6.1 10X Genomics Inc.
  • 15.6.2 Akoya Bioscience Ltd.
  • 15.6.3 Biospyder Technologies Inc.
  • 15.6.4 BioTechne Corporation.
  • 15.6.5 Dovetail Genomics LLC.
  • 15.6.6 Fluidigm Corporation.
  • 15.6.7 Genomic Vision SA.
  • 15.6.8 Illumina Inc.
  • 15.6.9 Lunaphore Technologies SA.
  • 15.6.10 Nanostring Technolgies Inc.

16. Strategic Recommendations